跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack - TGA Drug Approval Details
Approvals
/
TGA
/
ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack
Approved
STANDARD
ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack
Hetero Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2e8d856dd4c737df
Company
Hetero Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2e8d856dd4c737df
Product Name
ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, HDPE bottle pack
Artg Id
297924
Artg Name
ABALAMID HETERO 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, bottle pack
Sponsor
Hetero Australia Pty Ltd
Company Detail Path
/organization/hetero-australia-pty-ltd
Artg Date
2022-12-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d6668a2a89f7689d1c0244aa9ae089e8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2e8d856dd4c737df
Type
Standard
Back to TGA Approvals